Mediera Corporation (TPEX:5398)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.70
-0.05 (-0.24%)
Mar 10, 2026, 1:17 PM CST

Mediera Revenue

In the year 2025, Mediera had annual revenue of 229.85M TWD, down -3.62%. Mediera had revenue of 55.56M in the quarter ending December 31, 2025, a decrease of -15.83%.

Revenue
229.85M
Revenue Growth
-3.62%
P/S Ratio
4.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.02B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025229.85M-8.64M-3.62%
Dec 31, 2024238.48M45.59M23.63%
Dec 31, 2023192.90M-64.65M-25.10%
Dec 31, 2022257.55M-94.01M-26.74%
Dec 31, 2021351.56M-16.33M-4.44%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Prince Pharmaceutical 798.27M
Original BioMedicals 381.00K
Anxo Pharmaceutical 883.22M
Excelsior Biopharma 898.26M
DV Biomed 712.61M
Winston Medical Supply 724.35M
Bioray Biotech 230.06M
InnoPharmax 55.77M
Revenue Rankings